Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
Launched by CHILDREN'S HOSPITAL LOS ANGELES · Jun 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special support program called the Parent Navigator Program (PNP) can help Latino/x parents of babies born with congenital heart disease (a heart problem present at birth) better connect with important early development services. The study wants to find out if parents who get help through the PNP are more likely to use follow-up care for their high-risk infants, if their children show better development after six months, and if the parents experience less stress compared to those who receive regular care.
Babies eligible for this study are Latino/x infants who were born with heart problems requiring medical treatment within the first month of life. Their parents, who also need to identify as Latino/x and speak either English or Spanish, can join the study too. Families who participate will have their baby’s development checked at birth and again at six months. Those in the Parent Navigator group will receive weekly phone calls from a trained guide who helps them access services, and six months later, parents will be asked about their experience with the program. This study aims to support families in getting the care they need while also helping reduce stress during a challenging time.
Gender
ALL
Eligibility criteria
- Latino/x Infants:
- Inclusion Criteria:
- • Infants born with CHD requiring medical/surgical intervention at less than 30 days of age
- • Identify as Latino/x
- Exclusion Criteria:
- • Presence of a major genetic syndrome
- • Intraventricular hemorrhage or other major structural brain lesion
- • Undergoing end of life care
- Parents of Latino/x Infants:
- Inclusion Criteria:
- • Identify as Latino/x
- Exclusion Criteria:
- • Not fluent in English or Spanish
About Children's Hospital Los Angeles
Children's Hospital Los Angeles (CHLA) is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical care. As a leading clinical trial sponsor, CHLA is committed to conducting high-quality, ethical research that addresses critical pediatric health issues. With a focus on translating scientific discoveries into effective treatments, CHLA collaborates with multidisciplinary teams and leverages state-of-the-art facilities to support a wide range of clinical trials. Their mission is to enhance the understanding and treatment of childhood diseases, ultimately improving outcomes for young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Nhu Tran, PhD, RN
Principal Investigator
Children's Hospital Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported